首页> 外文期刊>The Journal of hospital infection >Mycobacterium terrae: a potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test.
【24h】

Mycobacterium terrae: a potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test.

机译:terra分枝杆菌:在标准消毒剂测试中,结核分枝杆菌的一种潜在替代物。

获取原文
获取原文并翻译 | 示例
           

摘要

The susceptibility of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare to the disinfections used for spillage and heat sensitive instruments has received much attention in recent years. The use of clinical isolates of M. tuberculosis and M. avium-intracellulare as test organisms is considered unsuitable for standard tests due to their hazardous nature (category 3 pathogens and slow growth rates). This has led to much debate in standards committees on the selection and use of a possible surrogate which would be safer and more practical to use and yet mimic the susceptibility of clinical isolates. This study compared the susceptibility of one possible surrogate Mycobacterium terrae NCTC 10856, with that of clinical isolates of M. tuberculosis H37 Rv and M. avium-intracellulare using a quantitative suspension test. The instrument and environmental disinfectants tested were a chlorine-releasing agent, sodium dichloroisocyanyurate (NaDCC) at 1000 ppm and 10,000 ppm av. Cl, chlorine dioxide at 1100 ppm av. ClO2 (Tristel, HayMan MediChem), 0.35% peracetic acid (NuCidex, Johnson & Johnson), 70% industrial methylated spirit (IMS), 2% alkaline glutaraldehyde (Asep, Galen), 10% succine dialdehyde and formaldehyde mixture (Gigasept, Schulke and Mayr). Results showed that the clinical isolate of M. avium-intracellulare was the most resistant of the three test organisms. M. terrae, which is not a category 3 pathogen, was slightly more resistant than M. tuberculosis and this would appear to be a suitable surrogate for establishing tuberculocidal activity. However, with an increase in the clinical significance of M. avium-intracellulare, particularly in human immunodeficiency virus (HIV) and immunocompromised patients, a more resistant surrogate is required. In the absence of such a surrogate, testing with M. avium-intracellulare in a clinical laboratory equipped for handling category 3 pathogens is still advised to establish mycobactericidal activity.
机译:近年来,结核分枝杆菌和细胞内鸟分枝杆菌对用于溢出物和热敏仪器的消毒剂的敏感性受到了广泛关注。由于其危险性(3类病原体和缓慢的生长速度),使用结核分枝杆菌和细胞内分枝杆菌和临床分离株作为测试生物被认为不适合标准测试。这在标准委员会中引起了关于选择和使用可能的替代品的更多争论,该替代品使用起来更安全,更实用,并且模仿了临床​​分离株的易感性。这项研究使用定量悬浮液试验比较了一种可能的替代分枝杆菌NCTC 10856与结核分枝杆菌H37 Rv和鸟分枝杆菌胞内临床分离株的敏感性。测试的仪器和环境消毒剂是氯释放剂,1000 ppm和10,000 ppm av的二氯异氰尿酸钠(NaDCC)。 Cl,1100 ppm av的二氧化氯。 ClO2(Tristel,HayMan MediChem),0.35%过氧乙酸(NuCidex,Johnson&Johnson),70%工业甲基化酒精(IMS),2%碱性戊二醛(Asep,Galen),10%琥珀二醛和甲醛混合物(Gigasept,Schulke和Mayr)。结果表明,鸟分枝杆菌胞内分枝杆菌的临床分离株在三种测试生物中抵抗力最强。不是第3类病原体的terra。M.抵抗力比结核M.略强,这似乎是建立结核杀灭活性的合适替代物。然而,随着鸟胞内支原体的临床意义的增加,特别是在人免疫缺陷病毒(HIV)和免疫功能低下的患者中,需要更具抵抗力的替代药物。在没有这种替代物的情况下,仍建议在装备有处理第3类病原体的临床实验室中用鸟笼内分枝杆菌进行测试以建立分枝杆菌活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号